Brazil’s former President Bolsonaro has surgery to treat hiccups, wife says
Brazil’s former President Bolsonaro has surgery to treat hiccups, wife says
Source link
Similar Posts
Top 5 High-Impact Economic Events This Week (April 6–12, 2026)
Top 5 High-Impact Economic Events This Week (April 6–12, 2026) Financial markets brace for a data-heavy week as central bank decisions, key inflation reports, and escalating geopolitical tensions take center stage. Below are the five events most likely to drive volatility across forex, equities, bonds, and energy markets — listed in chronological order (all times…
How to Bridge Machine Learning Predictions into MT5
Bridging Machine Learning Predictions into MT5 Overview: This post discusses challenges users face when ingesting custom data into MT5 algorithms and how utilizing the MML Data Bridge solves these issues. Finally, we discuss how to use the bridge MML Data Bridge acts as a data pipeline that drip-feeds static data into the back tester and…
An Ideal TFSA Stock With a Steady 5.3% Yield
For investors looking to put capital to work in their Tax-Free Savings Accounts (TFSAs) right now, there are plenty of great options to consider. Of course, high-yielding stocks should often be included in other registered retirement accounts, due to the tax benefits of doing so. However, for some investors, holding dividend-paying stocks that are viewed…
Tesla upgrades in-car navigation software in China, introduces lane-level guidance By Reuters
BEIJING (Reuters) – Tesla (NASDAQ:) released a software upgrade for its in-car navigation system in China on Friday, introducing new features such as displaying lane markings on its maps that correspond to the actual lanes on the road. The company announced the update on its official WeChat account along with a series of new features…
Wanbury Shares Shot-Up 5% as USFDA Issues 0 Observations – Equitypandit
June 20, 2024June 20, 2024 Shares of Wanbury Ltd were trading in the green and 5% higher on 20 June after the US Food and Drug Administration (USFDA) issued zero observation during its inspection of its Patalganga site. In its regulatory filing, the pharmaceutical company said, “We are happy…
